NTHI (NeOnc Technologies Holdings) Total Assets: $3.33 Mil (As of Mar. 2026)


NTHI NeOnc Technologies Holdings Inc NTHI
7 GF Score
Price $4.41
! 1 Warning Sign
View Full Analysis

What is NeOnc Technologies Holdings Total Assets?

NeOnc Technologies Holdings NTHI -0.90% 7 Total Assets is $3.33 Mil as of Mar. 2026. GuruFocus rates NTHI with a GF Score™ of 7/100. The stock has 1 warning sign investors should review.

NeOnc Technologies Holdings's Total Assets for the quarter that ended in Mar. 2026 was $3.33 Mil.

During the past 12 months, NeOnc Technologies Holdings's average Total Assets Growth Rate was 6.30% per year. During the past 3 years, the average Total Assets Growth Rate was 206.50% per year.

During the past 5 years, NeOnc Technologies Holdings's highest 3-Year average Total Assets Growth Rate was 682.40%. The lowest was 206.50%. And the median was 444.45%.

Total Assets is connected with ROA %. NeOnc Technologies Holdings's annualized ROA % for the quarter that ended in Mar. 2026 was -1,146.57%. Total Assets is also linked to Revenue through Asset Turnover. NeOnc Technologies Holdings's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

NeOnc Technologies Holdings  (NAS:NTHI) Total Assets Explanation

Total Assets is connected with ROA %.

NeOnc Technologies Holdings's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-35.28/( (2.824+3.33)/ 2 )
=-35.28/3.077
=-1,146.57 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

NeOnc Technologies Holdings's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (2.824+3.33)/ 2 )
=0/3.077
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

NeOnc Technologies Holdings Total Assets Related Terms

NeOnc Technologies Holdings Total Assets Historical Data

* Premium members only.

The historical data trend for NeOnc Technologies Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeOnc Technologies Holdings Total Assets Chart

NeOnc Technologies Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
0.03 0.73 1.27 3.42 2.82

NeOnc Technologies Holdings Quarterly Data
Dec21 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.44 2.99 4.08 2.82 3.33
NTHI
7GF Score
NeOnc Technologies Holdings Inc NTHI
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeOnc Technologies Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

NeOnc Technologies Holdings's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=-17.508+20.331
=2.82

NeOnc Technologies Holdings's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=-13.231+16.561
=3.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $3.33 Mil mean?
NeOnc Technologies Holdings (NTHI) has a Total Assets of $3.33 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on NeOnc Technologies Holdings and its competitors.
Is NeOnc Technologies Holdings' Total Assets too high?
NeOnc Technologies Holdings' current Total Assets is $3.33 Mil. Overall, NeOnc Technologies Holdings has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does NeOnc Technologies Holdings' Total Assets compare to GUTS and PEPG?
NeOnc Technologies Holdings' Total Assets of $3.33 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on NeOnc Technologies Holdings and its competitors. NeOnc Technologies Holdings's current Total Assets is $3.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeOnc Technologies Holdings stock overvalued right now?
NeOnc Technologies Holdings (NTHI) has a current Total Assets of $3.33 Mil. The current Total Assets is $3.33 Mil. NeOnc Technologies Holdings' overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For NeOnc Technologies Holdings (NTHI), the current Total Assets is $3.33 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NeOnc Technologies Holdings Business Description

Address 23975 Park Sorrento, Suite 205, Calabasas, CA, USA, 91302
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
7GF Score

Get the complete analysis for NTHI

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.41
Price